Viral diseases of the central nervous system

Topics in Magnetic Resonance Imaging

Volumn 16, Issue 2, 2005, Pages 189-212

  Leite, Claudia ^a   Barbosa Jr , Alcino ^a   Lucato, Leandro T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Central nervous system; Encephalitis; Meningitis; Myelitis; Viral diseases

Indexed keywords

BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENCEPHALOMYELITIS; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RASMUSSEN SYNDROME; RETROVIRUS; REVIEW; REYE SYNDROME; SPINE DISEASE; SUBACUTE SCLEROSING PANENCEPHALITIS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

CENTRAL NERVOUS SYSTEM INFECTIONS; ENCEPHALITIS; HUMANS; MAGNETIC RESONANCE IMAGING; MENINGITIS, VIRAL; MYELITIS;

EID: 33644839006     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rmr.0000189108.55275.12     Document Type: Review

References (287)

1. Kennedy PG. Viral encephalitis: causes, differential diagnosis, and management. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 1):i10-i15.
2. Maschke M, Kastrup O, Forsting M, et al. Update on neuroimaging in infectious central nervous system disease. Curr Opin Neurol. 2004;17:475-480.
3. Hansman Whiteman ML, Bowen BC, Donovan Post MJ, et al. Intracranial Infection. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:1099-1175.
4. Debiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev. 2004;17:903-925.
5. Tucker KA, Robertson KR, Lin W, et al. Neuroimaging in human immunodeficiency virus infection. J Neuroimmunol. 2004;157:153-162.
6. Shoji H, Wakasugi K, Miura Y, et al. Herpesvirus infections of the central nervous system. Jpn J Infect Dis. 2002;55:6-13.
7. Tien RD, Felsberg GJ, Osumi AK. Herpesvirus infections of the CNS: MR findings. AJR Am J Roentgenol. 1993;161:167-176.
8. Tang JW, Coward LJ, Davies NW, et al. Brain stem encephalitis caused by primary herpes simplex 2 infection in a young woman. J Neurol Neurosurg Psychiatry. 2003;74:1323-1325.
9. Domingues RB, Fink MC, Tsanaclis AM, et al. Diagnosis of herpes simplex encephalitis by magnetic resonance imaging and polymerase chain reaction assay of cerebrospinal fluid. J Neurol Sci. 1998;157:148-153.
10. Kennedy PG, Chaudhuri A. Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry. 2002;73:237-238.
11. Skoldenberg B. Herpes simplex encephalitis. Scand J Infect Dis Suppl. 1996;100:8-13.
12. McCabe K, Tyler K, Tanabe J. Diffusion-weighted MRI abnormalities as a clue to the diagnosis of herpes simplex encephalitis. Neurology. 2003;61:1015-1016.
13. Ohta HF, Tanaka M, Suzuki N. Early cerebellar involvement on diffusion-weighted magnetic resonance imaging in herpes simplex encephalitis. J Neurol. 1999;246:736-738.
14. Heiner L, Demaerel P. Diffusion-weighted MR imaging findings in a patient with herpes simplex encephalitis. Eur J Radiol. 2003;45:195-198.
15. Lee JW, Kim IO, Kim WS, et al. Herpes simplex encephalitis: MRI findings in two cases confirmed by polymerase chain reaction assay. Pediatr Radiol. 2001;31:619-623.
16. Burke JW, Mathews VP, Elster AD, et al. Contrast-enhanced magnetization transfer saturation imaging improves MR detection of herpes simplex encephalitis. AJNR Am J Neuroradiol. 1996;17:773-776.
17. Kuker W, Nagele T, Schmidt F, et al. Diffusion-weighted MRI in herpes simplex encephalitis: a report of three cases. Neuroradiology. 2004;46:122-125.
18. Gaviani P, Leone M, Mula M, et al. Progression of MRI abnormalities in herpes simplex encephalitis despite clinical improvement: natural history or disease progression? Neurol Sci. 2004;25:104-107.
19. Takanashi J, Sugita K, Ishii M, et al. Longitudinal MR imaging and proton MR spectroscopy in herpes simplex encephalitis. J Neurol Sci. 1997;149:99-102.
20. Coren ME, Buchdahl RM, Cowan FM, et al. Imaging and laboratory investigation in herpes simplex encephalitis. J Neurol Neurosurg Psychiatry. 1999;67:243-245.
21. Teixeira J, Zimmerman RA, Haselgrove JC, et al. Diffusion imaging in pediatric central nervous system infections. Neuroradiology. 2001;43:1031-1039.
22. Leonard JR, Moran CJ, Cross DT 3rd, et al. MR imaging of herpes simplex type 1 encephalitis in infants and young children: a separate pattern of findings. AJR Am J Roentgenol. 2000;174:1651-1655.
23. Schlesinger Y, Buller RS, Brunstrom JE, et al. Expanded spectrum of herpes simplex encephalitis in childhood. J Pediatr. 1995;126:234-241.
24. Suzuki F, Furuta Y, Ohtani F, et al. Herpes virus reactivation and gadolinium-enhanced magnetic resonance imaging in patients with facial palsy. Otol Neurotol. 2001;22:549-553.
25. Kuker W, Schaade L, Ritter K, et al. MRI follow-up of herpes simplex virus (type 1) radiculomyelitis. Neurology. 1999;52:1102-1103.
26. Tang WY, Lo JY, Yuen MK, et al. Herpes simplex virus type 2 infection in a 5-year-old boy presenting with recurrent chest wall vesicles and a possible history of herpes encephalitis. Br J Dermatol. 1997;137:440-444.
27. Enzmann D, Chang Y, Augustyn G. MR findings in neonatal herpes encephalitis type II. J Comput Assist Tomogr. 1990;14:453-457.
28. Bonthius DJ, Karacay B. Meningitis and encephalitis in children. An update. Neurol Clin. 2002;20:1013-1038.
29. Kato Z, Kozawa R, Teramoto T, et al. Acute cerebellitis in primary human herpesvirus-6 infection. Eur J Pediatr. 2003;162:801-803.
30. Kalayjian RC, Cohen ML, Bonomo RA, et al. Cytomegalovirus ventriculoencephalitis in AIDS. A syndrome with distinct clinical and pathologic features. Medicine (Baltimore). 1993;72:67-77.
31. Boesch C, Issakainen J, Kewitz G, et al. Magnetic resonance imaging of the brain in congenital cytomegalovirus infection. Pediatr Radiol. 1989;19:91-93.
32. Malm G, Grondahl EH, Lewensohn-Fuchs I. Congenital cytomegalovirus infection: a retrospective diagnosis in a child with pachygyria. Pediatr Neurol. 2000;22:407-408.
33. Iannetti P, Nigro G, Spalice A, et al. Cytomegalovirus infection and schizencephaly: case reports. Ann Neurol. 1998;43:123-127.
34. Zucca C, Binda S, Borgatti R, et al. Retrospective diagnosis of congenital cytomegalovirus infection and cortical maldevelopment. Neurology. 2003;61:710-712.
35. Numazaki K. Retrospective diagnosis of congenital cytomegalovirus infection and cortical maldevelopment. Neurology. 2004;62:1453-1454 [author reply 1454].
36. Barkovich AJ, Girard N. Fetal brain infections. Childs Nerv Syst. 2003;19:501-507.
37. Arata MA, Provenzale JM, Vredenburgh JJ. Cytomegalovirus encephalomyelitis: MR imaging findings documenting response to ganciclovir therapy. AJR Am J Roentgenol. 1998;171:103-105.
38. Holland NR, Power C, Mathews VP, et al. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology. 1994;44:507-514.
39. Rubin DI. NeuroImages. "Owl's eyes" of CMV ventriculitis. Neurology. 2000;54:2217.
40. Salazar A, Podzamczer D, Rene R, et al. Cytomegalovirus ventriculoencephalitis in AIDS patients. Scand J Infect Dis. 1995;27:165-169.
41. Bazan C 3rd, Jackson C, Jinkins JR, et al. Gadolinium-enhanced MRI in a case of cytomegalovirus polyradiculopathy. Neurology. 1991;41:1522-1523.
42. Tenenbaum T, Kramm CM, Laws HJ, et al. Pre-eruptive varicella zoster virus encephalitis in two children after haematopoietic stem cell transplantation. Med Pediatr Oncol. 2002;38:288-289.
43. Wagner HJ, Seidel A, Grande-Nagel I, et al. Pre-eruptive varicella encephalitis: case report and review of the literature. Eur J Pediatr. 1998;157:814-815.
44. Lentz D, Jordan JE, Pike GB, et al. MRI in varicella-zoster virus leukoencephalitis in the immunocompromised host. J Comput Assist Tomogr. 1993;17:313-316.
45. Haanpaa M, Dastidar P, Weinberg A, et al. CSF and MRI findings in patients with acute herpes zoster. Neurology. 1998;51:1405-1411.
46. Fujimoto H, Asaoka K, Imaizumi T, et al. Epstein-Barr virus infections of the central nervous system. Intern Med. 2003;42:33-40.
47. Garamendi I, Montejo M, Cancelo L, et al. Encephalitis caused by Epstein-Barr virus in a renal transplant recipient. Clin Infect Dis. 2002;34:287-288.
48. Ono J, Shimizu K, Harada K, et al. Characteristic MR features of encephalitis caused by Epstein-Barr virus: a case report. Pediatr Radiol. 1998;28:569-570.
49. Johkura K, Momoo T, Kuroiwa Y. Thalamic involvement of Epstein-Barr virus encephalitis demonstrated by MRI. J Neurol. 2003;250:357-358.
50. Van Lierde A, Righini A, Tremolati E. Acute cerebellitis with tonsillar herniation and hydrocephalus in Epstein-Barr virus infection. Eur J Pediatr. 2004;163:689-691.
51. Shian WJ, Chi CS. Epstein-Barr virus encephalitis and encephalomyelitis: MR findings. Pediatr Radiol. 1996;26:690-693.
52. Angelini L, Bugiani M, Zibordi F, et al. Brainstem encephalitis resulting from Epstein-Barr virus mimicking an infiltrating tumor in a child. Pediatr Neurol. 2000;22:130-132.
53. Tolly TL, Wells RG, Sty JR. MR features of fleeting CNS lesions associated with Epstein-Barr virus infection. J Comput Assist Tomogr. 1989;13:665-668.
54. Donovan WD, Zimmerman RD. Case report. MRI findings of severe Epstein-Barr virus encephalomyelitis. J Comput Assist Tomogr. 1996;20:1027-1029.
55. Tselis A, Duman R, Storch GA, et al. Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology. 1997;48:1351-1355.
56. Goff SP. Retroviridae: the retroviruses and their replication. In: Griffin DE, ed. Fields' Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:1872-1939.
57. Victor M, Ropper AH, Adams RD. Viral infections of the nervous system and prion diseases. In: Victor M, Ropper AH, Adams RD, eds. Adams and Victor's Principles of Neurology. 7th ed. New York: Medical Pub. Division, McGraw-Hill; 2001:783-820.
58. Engels EA, Goedert JJ. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future. J Natl Cancer Inst. 2005;97:407-409.
59. Bell JE. The neuropathology of adult HIV infection. Rev Neurol (Paris). 1998;154:816-829.
60. Petito CK. Review of central nervous system pathology in human immunodeficiency virus infection. Ann Neurol. 1988;23(Suppl):S54-S57.
61. Joseph J, Sharp B, Fox HS, et al. Editorial. J Neuroimmunol. 2004;157:1-2.
62. Martinez AJ, Sell M, Mitrovics T, et al. The neuropathology and epidemiology of AIDS. A Berlin experience. A review of 200 cases. Pathol Res Pract. 1995;191:427-443.
63. Sharer LR, Kapila R. Neuropathologic observations in acquired immunodeficiency syndrome (AIDS). Acta Neuropathol (Berl). 1985;66:188-198.
64. Navia BA, Cho ES, Petito CK, et al. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986;19:525-535.
65. Gray F, Keohane C. The neuropathology of HIV infection in the era of Highly Active AntiRetroviral Therapy (HAART). Brain Pathol. 2003;13:79-83.
66. Dallasta LM, Pisarov LA, Esplen JE, et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol. 1999;155:1915-1927.
67. Persidsky Y. Model systems for studies of leukocyte migration across the blood - brain barrier. J Neurovirol. 1999;5:579-590.
68. Persidsky Y, Ghorpade A, Rasmussen J, et al. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol. 1999;155:1599-1611.
69. Langford TD, Letendre SL, Larrea GJ, et al. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol. 2003;13:195-210.
70. Gray F, Adle-Biassette H, Chretien F, et al. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol. 2001;20:146-155.
71. Kleihues P, Leib SL, Strittmatter C, et al. HIV encephalopathy: incidence, definition and pathogenesis. Results of a Swiss collaborative study. Acta Pathol Jpn. 1991;41:197-205.
72. Budka H, Wiley CA, Kleihues P, et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991;1:143-152.
73. Grassi MP, Clerici F, Boldorini R, et al. HIV encephalitis and HIV leukoencephalopathy are associated with distinct clinical and radiological subtypes of the AIDS dementia complex. AIDS. 1997;11:690-691.
74. Thurnher MM, Schindler EG, Thurnher SA, et al. Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course. AJNR Am J Neuroradiol. 2000;21:670-678.
75. Working Group of the American Academy. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41:778-785.
76. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19:517-524.
77. Robertson KR, Hall CD. Human immunodeficiency virus-related cognitive impairment and the acquired immunodeficiency syndrome dementia complex. Semin Neurol. 1992;12:18-27.
78. Heaton RK, Grant I, Butters N, et al. The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995;1:231-251.
79. McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol. 2004;157:3-10.
80. Elovaara I, Poutiainen E, Raininko R, et al. Mild brain atrophy in early HIV infection: the lack of association with cognitive deficits and HIV-specific intrathecal immune response. J Neurol Sci. 1990;99:121-136.
81. Price TA, Digioia RA, Simon GL. Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus. Clin Infect Dis. 1992;15:606-608.
82. Price RW. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system. Res Publ Assoc Res Nerv Ment Dis. 1994;72:1-45.
83. Cherner M, Masliah E, Ellis RJ, et al. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology. 2002;59:1563-1567.
84. Bell JE, Donaldson YK, Lowrie S, et al. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS. 1996;10:493-499.
85. Raja F, Sherriff FE, Morris CS, et al. Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol (Berl). 1997;93:184-189.
86. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985;62:475-495.
87. Chrysikopoulos HS, Press GA, Grafe MR, et al. Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology. 1990;175:185-191.
88. Post MJ, Berger JR, Quencer RM. Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. Radiology. 1991;178:131-139.
89. Archibald SL, Masliah E, Fennema-Notestine C, et al. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol. 2004;61:369-376.
90. Olsen WL, Longo FM, Mills CM, et al. White matter disease in AIDS: findings at MR imaging. Radiology. 1988;169:445-448.
91. Post MJ. Fluid-attenuated inversion-recovery fast spin-echo MR: a clinically useful tool in the evaluation of neurologically symptomatic HIV-positive patients. AJNR Am J Neuroradiol. 1997;18:1611-1616.
92. Post MJ, Tate LG, Quencer RM, et al. CT, MR, and pathology in HIV encephalitis and meningitis. AJR Am J Roentgenol. 1988;151:373-380.
93. Post MJ, Levin BE, Berger JR, et al. Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects. AJNR Am J Neuroradiol. 1992;13:359-370.
94. Post MJ, Berger JR, Duncan R, et al. Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long-term MR imaging and clinical follow-up. Radiology. 1993;188:727-733.
95. Avison MJ, Nath A, Greene-Avison R, et al. Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol. 2004;157:140-146.
96. Hall M, Whaley R, Robertson K, et al. The correlation between neuropsychological and neuroanatomic changes over time in asymptomatic and symptomatic HIV-1-infected individuals. Neurology. 1996;46:1697-1702.
97. Stout JC, Ellis RJ, Jernigan TL, et al. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol. 1998;55:161-168.
98. Jernigan TL, Archibald S, Hesselink JR, et al. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol. 1993;50:250-255.
99. Yiannoutsos CT, Ernst T, Chang L, et al. Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage. 2004;23:928-935.
100. Harrison MJ, Newman SP, Hall-Craggs MA, et al. Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study. J Neurol Neurosurg Psychiatry. 1998;65:301-307.
101. Chong WK, Sweeney B, Wilkinson ID, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology. 1993;188:119-124.
102. Wilkinson ID, Lunn S, Miszkiel KA, et al. Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS. J Neurol Neurosurg Psychiatry. 1997;63:477-482.
103. Ernst T, Chang L. Effect of aging on brain metabolism in antiretroviral-naive HIV patients. AIDS. 2004;18(Suppl 1):S61-S67.
104. Lee PL, Yiannoutsos CT, Ernst T, et al. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging. 2003;17:625-633.
105. Suwanwelaa N, Phanuphak P, Phanthumchinda K, et al. Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. Magn Reson Imaging. 2000;18:859-865.
106. Chang L, Ernst T, Leonido-Yee M, et al. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology. 1999;52:100-108.
107. Chang L, Speck O, Miller EN, et al. Neural correlates of attention and working memory deficits in HIV patients. Neurology. 2001;57:1001-1007.
108. Filippi CG, Ulug AM, Ryan E, et al. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. AJNR Am J Neuroradiol. 2001;22:277-283.
109. Ragin AB, Storey P, Cohen BA, et al. Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol. 2004;25:195-200.
110. Cloak CC, Chang L, Ernst T. Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV. J Neuroimmunol. 2004;157:147-152.
111. Chang L, Ernst T, Leonido-Yee M, et al. Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology. 2000;54:389-396.
112. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
113. Gray F, Chretien F, Vallat-Decouvelaere AV, et al. The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol. 2003;62:429-440.
114. Ammassari A, Cingolani A, Pezzotti P, et al. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology. 2000;55:1194-1200.
115. Pialoux G, Fournier S, Moulignier A, et al. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS. 1997;11:1302-1303.
116. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8:136-142.
117. Schifitto G, McDermott MP, McArthur JC, et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology. 2002;58:1764-1768.
118. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore). 2002;81:213-227.
119. Collazos J, Mayo J, Martinez E, et al. Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS. 1999;13:1426-1428.
120. French MA. Antiretroviral therapy. Immune restoration disease in HIV-infected patients on HAART. AIDS Read. 1999;9:548-562.
121. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med. 2000;133:447-454.
122. Stoll M, Schmidt RE. Adverse events of desirable gain in immunocompetence: the Immune Restoration Inflammatory Syndromes. Autoimmun Rev. 2004;3:243-249.
123. Langford TD, Letendre SL, Marcotte TD, et al. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS. 2002;16:1019-1029.
124. Filippi CG, Sze G, Farber SJ, et al. Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy. Radiology. 1998;206:491-498.
125. Stankoff B, Tourbah A, Suarez S, et al. Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology. 2001;56:112-115.
126. Chang L, Ernst T, Leonido-Yee M, et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology. 1999;53:782-789.
127. Chang L, Ernst T, Witt MD, et al. Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART. Antivir Ther. 2003;8:17-26.
128. Chang L, Ernst T, St Hillaire C, et al. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients. Antivir Ther. 2004;9:431-440.
129. Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004;109:1603-1608.
130. Thurnher MM, Post MJ, Jinkins JR. MRI of infections and neoplasms of the spine and spinal cord in 55 patients with AIDS. Neuroradiology. 2000;42:551-563.
131. Petito CK, Cho ES, Lemann W, et al. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol. 1986;45:635-646.
132. Mendonca RA. Spinal infection and inflammatory disorders. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:1855-1969.
133. Taber KH, Hayman LA, Shandera WX, et al. Spinal disease in neurologically symptomatic HIV-positive patients. Neuroradiology. 1999;41:360-368.
134. Henin D, Smith TW, De Girolami U, et al. Neuropathology of the spinal cord in the acquired immunodeficiency syndrome. Hum Pathol. 1992;23:1106-1114.
135. Sartoretti-Schefer S, Blattler T, Wichmann W. Spinal MRI in vacuolar myelopathy, and correlation with histopathological findings. Neuroradiology. 1997;39:865-869.
136. Petito CK, Navia BA, Cho ES, et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985;312:874-879.
137. Quencer RM. AIDS-associated myelopathy: clinical severity, MR findings, and underlying etiologies. AJNR Am J Neuroradiol. 1999;20:1387-1388.
138. Geny C, Gherardi R, Boudes P, et al. Multifocal multinucleated giant cell myelitis in an AIDS patient. Neuropathol Appl Neurobiol. 1991;17:157-162.
139. Blanche S, Mayaux MJ, Rouzioux C, et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med. 1994;330:308-312.
140. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996;335:1621-1629.
141. Tardieu M, Brunelle F, Raybaud C, et al. Cerebral MR imaging in uninfected children born to HIV-seropositive mothers and perinatally exposed to zidovudine. AJNR Am J Neuroradiol. 2005;26:695-701.
142. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 1999;354:1084-1089.
143. Culnane M, Fowler M, Lee SS, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA. 1999;281:151-157.
144. Post MJ. A new challenge for the neuroradiologist: MR recognition of mitochondrial dysfunction in children born of HIV-seropositive mothers on antiretroviral therapy. AJNR Am J Neuroradiol. 2005;26:687-689.
145. Scott GB. Perinatal exposure to antiretroviral agents: risks and benefits. AJNR Am J Neuroradiol. 2005;26:689-692.
146. Barkovich AJ. Infections of the nervous system. In: Barkovich AJ, ed. Pediatric Neuroimaging. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:715-770.
147. Belman AL, Diamond G, Dickson D, et al. Pediatric acquired immunodeficiency syndrome. Neurologic syndromes. Am J Dis Child. 1988;142:29-35.
148. Roy S, Geoffroy G, Lapointe N, et al. Neurological findings in HIV-infected children: a review of 49 cases. Can J Neurol Sci. 1992;19:453-457.
149. Weil ML, Tuomanen E, Israele V, et al. Infections of the nervous system. In: Menkes JH, Sarnat HB, eds. Textbook of Child Neurology. 6th ed. Baltimore: Lippincott Williams & Wilkins; 2000:467-626.
150. Joshi VV, Pawel B, Connor E, et al. Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol. 1987;7:261-275.
151. Price DB, Inglese CM, Jacobs J, et al. Pediatric AIDS. Neuroradiologic and neurodevelopmental findings. Pediatr Radiol. 1988;18:445-448.
152. Kauffman WM, Sivit CJ, Fitz CR, et al. CT and MR evaluation of intracranial involvement in pediatric HIV infection: a clinical-imaging correlation. AJNR Am J Neuroradiol. 1992;13:949-957.
153. DeCarli C, Civitello LA, Brouwers P, et al. The prevalence of computed tomographic abnormalities of the cerebrum in 100 consecutive children symptomatic with the human immune deficiency virus. Ann Neurol. 1993;34:198-205.
154. Chamberlain MC, Nichols SL, Chase CH. Pediatric AIDS: comparative cranial MRI and CT scans. Pediatr Neurol. 1991;7:357-362.
155. Scarmato V, Frank Y, Rozenstein A, et al. Central brain atrophy in childhood AIDS encephalopathy. AIDS. 1996;10:1227-1231.
156. States LJ, Zimmerman RA, Rutstein RM. Imaging of pediatric central nervous system HIV infection. Neuroimaging Clin N Am. 1997;7:321-339.
157. Gillams AR, Allen E, Hrieb K, et al. Cerebral infarction in patients with AIDS. AJNR Am J Neuroradiol. 1997;18:1581-1585.
158. Frank Y, Lim W, Kahn E, et al. Multiple ischemic infarcts in a child with AIDS, varicella zoster infection, and cerebral vasculitis. Pediatr Neurol. 1989;5:64-67.
159. Dubrovsky T, Curless R, Scott G, et al. Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology. 1998;51:560-565.
160. Park YD, Belman AL, Kim TS, et al. Stroke in pediatric acquired immunodeficiency syndrome. Ann Neurol. 1990;28:303-311.
161. Patsalides AD, Wood LV, Atac GK, et al. Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings. AJR Am J Roentgenol. 2002;179:999-1003.
162. Frank Y, Lu D, Pavlakis S, et al. Childhood AIDS, varicella zoster, and cerebral vasculopathy. J Child Neurol. 1997;12:464-466.
163. Salvan AM, Lamoureux S, Michel G, et al. Localized proton magnetic resonance spectroscopy of the brain in children infected with human immunodeficiency virus with and without encephalopathy. Pediatr Res. 1998;44:755-762.
164. Lu D, Pavlakis SG, Frank Y, et al. Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology. 1996;199:423-428.
165. Pavlakis SG, Lu D, Frank Y, et al. Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy. AJNR Am J Neuroradiol. 1998;19:383-385.
166. Imirizaldu JJ, Esteban JC, Axpe IR, et al. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry. 2003;74:1080-1084.
167. Ribas JG, Melo GC. [Human T-cell lymphotropic virus type 1(HTLV-1)-associated myelopathy.] Rev Soc Bras Med Trop. 2002;35:377-384.
168. Shakudo MI, Tsutada T. HTLV-1 associated myelopathy: acute progression and atypical MR findings. Am J Neuroradiol. 1999;20:1417-1421.
169. Melo A, Moura L, Rios S, et al. Magnetic resonance imaging in HTLV-I associated myelopathy. Arq Neuropsiquiatr. 1993;51:329-332.
170. Ogata AN, Tashiro K, et al. MRI-pathologic correlate brain lesion in a necropsy case of HTLV-1 associated myelopathy. J Neurol Neurosurg Psychiatry. 1993;56:194-196.
171. Douen AG, Pringle CE, Guberman A. Human T-cell lymphotropic virus type 1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis. Arch Neurol. 1997;54:896-900.
172. Howard AK, Li DK, Oger J. MRI contributes to the differentiation between MS and HTLV-1 associated myelopathy in British Columbian coastal natives. Can J Neurol Sci. 2003;30:41-48.
173. Kreger LG, Nieman E. Magnetic resonance imaging in an HTLV-1 antibody positive patient with spastic paraparesis. J Neurol Neurosurg Psychiatry. 1988;51:999.
174. Miller DH, Newton MR, Rudge P, et al. Magnetic resonance imaging in HTLV-1 antibody positive patients. Lancet. 1987;2:514.
175. Kawano YK. J. Chronic hypertrophic cranial pachymeningitis associated with HTLV-1 infection. J Neurol Neurosurg Psychiatry. 1995;59:435-437.
176. Major EO. Human polyomavirus. In: Fields BN, Knipe DM, Howley PM, et al., eds. Fields' Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:2175-2196.
177. Aksamit AJ Jr. Progressive multifocal leukoencephalopathy: a review of the pathology and pathogenesis. Microsc Res Tech. 1995;32:302-311.
178. Major EO, Amemiya K, Tornatore CS, et al. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 1992;5:49-73.
179. Koralnik IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol. 2004;17:365-370.
180. Du Pasquier RA, Corey S, Margolin DH, et al. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology. 2003;61:775-782.
181. Stolt A, Sasnauskas K, Koskela P, et al. Seroepidemiology of the human polyomaviruses. J Gen Virol. 2003;84:1499-1504.
182. Lima MA, Hanto DW, Curry MP, et al. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation. J Neurovirol. 2005;11:46-50.
183. Kiewe P, Seyfert S, Korper S, et al. Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. Leak Lymphoma. 2003;44:1815-1818.
184. Colucci M, Cocito L, Capello E, et al. Progressive multifocal leukoencephalopathy in an adult patient with ICF syndrome. J Neurol Sci. 2004;217:107-110.
185. Pagnoux C, Hayem G, Roux F, et al. JC virus leukoencephalopathy complicating Wegener's granulomatosis. Joint Bone Spine. 2003;70:376-379.
186. Manji H, Miller RF. Progressive multifocal leucoencephalopathy: progress in the AIDS era. J Neurol Neurosurg Psychiatry. 2000;69:569-571.
187. Wolinsky JS, McArthur JC. Slow virus infections in the nervous system, including AIDS. In: Humes HD, DuPont HL, Gardner LB, et al., eds. Kelley's Textbook of Internal Medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:2953-2958.
188. Whiteman ML, Post MJ, Berger JR, et al. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 1993;187:233-240.
189. Post MJ, Yiannoutsos C, Simpson D, et al. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol. 1999;20:1896-1906.
190. Sarrazin JL, Soulie D, Derosier C, et al. MRI aspects of progressive multifocal leukoencephalopathy. J Neuroradiol. 1995;22:172-179.
191. Mark AS, Atlas SW. Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images. Radiology. 1989;173:517-520.
192. Trotot PM, Vazeux R, Yamashita HK, et al. MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS. Pathological correlations. J Neuroradiol. 1990;17:233-254.
193. Garrels K, Kucharczyk W, Wortzman G, et al. Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. AJNR Am J Neuroradiol. 1996;17:597-600.
194. Wheeler AL, Truwit CL, Kleinschmidt-DeMasters BK, et al. Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images. AJR Am J Roentgenol. 1993;161:1049-1051.
195. Bergui M, Bradac GB, Oguz KK, et al. Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology. 2004;46:22-25.
196. Mader I, Herrlinger U, Klose U, et al. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology. 2003;45:717-721.
197. Dousset V, Armand JP, Lacoste D, et al. Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. AJNR Am J Neuroradiol. 1997;18:895-901.
198. Dousset V, Armand JP, Huot P, et al. Magnetization transfer imaging in AIDS-related brain diseases. Neuroimaging Clin N Am. 1997;7:447-460.
199. Thurnher MM, Thurnher SA, Fleischmann D, et al. Comparison of T2-weighted and fluid-attenuated inversion-recovery fast spin-echo MR sequences in intracerebral AIDS-associated disease. AJNR Am J Neuroradiol. 1997;18:1601-1609.
200. Chang L, Ernst T, Tornatore C, et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology. 1997;48:836-845.
201. Katz-Brull R, Lenkinski RE, Du Pasquier RA, et al. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology. 2004;63:897-900.
202. Berger JR, Kaszovitz B, Post MJ, et al. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med. 1987;107:78-87.
203. Karahalios D, Breit R, Dal Canto MC, et al. Progressive multifocal leukoencephalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. J Acquir Immune Defic Syndr. 1992;5:1030-1038.
204. Hall CD, Dafni U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med. 1998;338:1345-1351.
205. Thurnher MM, Post MJ, Rieger A, et al. Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol. 2001;22:977-984.
206. Hoffmann C, Horst HA, Albrecht H, et al. Progressive multifocal leucoencephalopathy with unusual inflammatory response during antiretroviral treatment. J Neurol Neurosurg Psychiatry. 2003;74:1142-1144.
207. Kotecha N, George MJ, Smith TW, et al. Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status? Am J Med. 1998;105:541-543.
208. Kim SJ, Kim JS, Lee DY. Neurologic outcome of acute measles encephalitis according to the MRI patterns. Pediatr Neurol. 2003;28:281-284.
209. Kanemura H, Aihara M, Okubo T, et al. Sequential 3-D MRI frontal volume changes in subacute sclerosing panencephalitis. Brain Dev. 2005;27:148-151.
210. Cakmakci H, Kurul S, Iscan A, et al. Proton magnetic resonance spectroscopy in three subacute sclerosing panencephalitis patients: correlation with clinical status. Childs Nerv Syst. 2004;20:216-220.
211. Brismar J, Gascon GG, von Steyern KV, et al. Subacute sclerosing panencephalitis: evaluation with CT and MR. AJNR Am J Neuroradiol. 1996;17:761-772.
212. Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J. 2002;78:63-70.
213. Alkan A, Sarac K, Kutlu R, et al. Early- and late-state subacute sclerosing panencephalitis: chemical shift imaging and single-voxel MR spectroscopy. AJNR Am J Neuroradiol. 2003;24:501-506.
214. Akdal G, Baklan B, Cakmakci H, et al. MRI follow-up of basal ganglia involvement in subacute sclerosing panencephalitis. Pediatr Neurol. 2001;24:393-395.
215. Alexander M, Singh S, Gnanamuthu C, et al. Subacute sclerosing panencephalitis: CT and MR imaging in a rapidly progressive case. Neurol India. 1999;47:304-307.
216. Anlar B, Yalaz K, Saatci I. Bilateral temporal cysts in a case of subacute sclerosing panencephalitis. Eur J Paediatr Neurol. 2003;7:81-84.
217. Tuncay R, Akman-Demir G, Gokyigit A, et al. MRI in subacute sclerosing panencephalitis. Neuroradiology. 1996;38:636-640.
218. Anlar B, Saatci I, Kose G, et al. MRI findings in subacute sclerosing panencephalitis. Neurology. 1996;47:1278-1283.
219. Sener RN. Subacute sclerosing panencephalitis findings at MR imaging, diffusion MR imaging, and proton MR spectroscopy. AJNR Am J Neuroradiol. 2004;25:892-894.
220. Salvan AM, Confort-Gouny S, Cozzone PJ, et al. In vivo cerebral proton MRS in a case of subacute sclerosing panencephalitis. J Neurol Neurosurg Psychiatry. 1999;66:547-548.
221. Sener RN. Subacute sclerosing panencephalitis with pontine involvement. J Comput Assist Tomogr. 2004;28:101-102.
222. Mader I, Wolff M, Nagele T, et al. MRI and proton MR spectroscopy in acute disseminated encephalomyelitis. Childs Nerv Syst. 2005: Epub ahead of print.
223. Mader I, Wolff M, Niemann G, et al. Acute haemorrhagic encephalomyelitis (AHEM): MRI findings. Neuropediatrics. 2004;35:143-146.
224. Dale RC, de Sousa C, Chong WK, et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000;123:2407-2422.
225. Ohtake T, Hirai S. Recurrence of acute disseminated encephalomyelitis after a 12-year symptom-free interval. Intern Med. 2004;43:746-749.
226. Schwarz S, Mohr A, Knauth M, et al. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001;56:1313-1318.
227. Victor M, Ropper AH, Adams RD. Multiple sclerosis and allied demyelinative diseases. In: Victor M, Ropper AH, Adams RD, eds. Adams and Victor's Principles of Neurology. 7th ed. New York: Medical Pub. Division, McGraw-Hill; 2001:954-982.
228. Stuv O, Zamvil SS. Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis. Curr Opin Neurol. 1999;12:395-401.
229. Kuker W, Ruff J, Gaertner S, et al. Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging. Neuroradiology. 2004;46:421-426.
230. Nasr JT, Andriola MR, Coyle PK. ADEM: literature review and case report of acute psychosis presentation. Pediatr Neurol. 2000;22:8-18.
231. Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J. 2003;79:11-17.
232. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 2002;59:1224-1231.
233. Khong PL, Ho HK, Cheng PW, et al. Childhood acute disseminated encephalomyelitis: the role of brain and spinal cord MRI. Pediatr Radiol. 2002;32:59-66.
234. Lukes SA, Norman D. Computed tomography in acute disseminated encephalomyelitis. Ann Neurol. 1983;13:567-572.
235. Caldemeyer KS, Smith RR, Harris TM, et al. MRI in acute disseminated encephalomyelitis. Neuroradiology. 1994;36:216-220.
236. Atlas SW, Grossman RI, Goldberg HI, et al. MR diagnosis of acute disseminated encephalomyelitis. J Comput Assist Tomogr. 1986;10:798-801.
237. Hynson JL, Kornberg AJ, Coleman LT, et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001;56:1308-1312.
238. Caldemeyer KS, Harris TM, Smith RR, et al. Gadolinium enhancement in acute disseminated encephalomyelitis. J Comput Assist Tomogr. 1991;15:673-675.
239. Honkaniemi J, Dastidar P, Kahara V, et al. Delayed MR imaging changes in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol. 2001;22:1117-1124.
240. Inglese M, Salvi F, Iannucci G, et al. Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis. AJNR Am J Neuroradiol. 2002;23:267-272.
241. Fu L, Matthews PM, De Stefano N, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain. 1998;121:103-113.
242. Ge Y, Grossman RI, Udupa JK, et al. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J Comput Assist Tomogr. 2002;26:62-68.
243. Cassol E, Ranjeva JP, Ibarrola D, et al. Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter. Mult Scler. 2004;10:188-196.
244. Bizzi A, Ulug AM, Crawford TO, et al. Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol. 2001;22:1125-1130.
245. O'Riordan JI, Gomez-Anson B, Moseley IF, et al. Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci. 1999;167:132-136.
246. Chiapparini L, Granata T, Farina L, et al. Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis? Neuroradiology. 2003;45:171-183.
247. Hart Y. Rasmussen's encephalitis. Epileptic Disord. 2004;6:133-144.
248. Velkey I, Lombay B. Neuroimaging of Rasmussen's encephalitis. Pediatr Radiol. 1993;23:487-488.
249. Bien CG, Widman G, Urbach H, et al. The natural history of Rasmussen's encephalitis. Brain. 2002;125:1751-1759.
250. Bien CG, Urbach H, Deckert M, et al. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology. 2002;58:250-257.
251. McLachlan RS, Girvin JP, Blume WT, et al. Rasmussen's chronic encephalitis in adults. Arch Neurol. 1993;50:269-274.
252. Fogarasi A, Hegyi M, Neuwirth M, et al. Comparative evaluation of concomitant structural and functional neuroimages in Rasmussen's encephalitis. J Neuroimaging. 2003;13:339-345.
253. Tien RD, Ashdown BC, Lewis DV Jr, et al. Rasmussen's encephalitis: neuroimaging findings in four patients. AJR Am J Roentgenol. 1992;158:1329-1332.
254. Bhatjiwale MG, Polkey C, Cox TC, et al. Rasmussen's encephalitis: neuroimaging findings in 21 patients with a closer look at the basal ganglia. Pediatr Neurosurg. 1998;29:142-148.
255. Koehn MA, Zupanc ML. Unusual presentation and MRI findings in Rasmussen's syndrome. Pediatr Neurol. 1999;21:839-842.
256. Sener RN. Diffusion MRI and spectroscopy in Rasmussen's encephalitis. Eur Radiol. 2003;13:2186-2191.
257. Sundgren PC, Burtscher IM, Lundgren J, et al. MRI and proton spectroscopy in a child with Rasmussen's encephalitis. Case report. Neuroradiology. 1999;41:935-940.
258. Wright PF, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DM, Howley PM, et al., eds. Fields' Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:1533-1579.
259. De Vivo DC. Reye Syndrome. In: Merritt HH, Rowland LP, eds. Merritt's Neurology. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:205-206.
260. Ozawa H, Sasaki M, Sugai K, et al. Single-photon emission CT and MR findings in Kluver-Bucy syndrome after Reye syndrome. AJNR Am J Neuroradiol. 1997;18:540-542.
261. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999;340:1377-1382.
262. Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003;28:225-232.
263. Barrett MJ, Hurwitz ES, Schonberger LB, et al. Changing epidemiology of Reye syndrome in the United States. Pediatrics. 1986;77:598-602.
264. Hardie RM, Newton LH, Bruce JC, et al. The changing clinical pattern of Reye's syndrome 1982-1990. Arch Dis Child. 1996;74:400-405.
265. Victor M, Ropper AH, Adams RD. The acquired metabolic disorders of the nervous system. In: Victor M, Ropper AH, Adams RD, eds. Adams and Victor's Principles of Neurology. 7th ed. New York: Medical Pub. Division, McGraw-Hill; 2001:1175-1204.
266. Partin JC, Schubert WK, Partin JS. Mitochondrial ultrastructure in Reye's syndrome (encephalopathy and fatty degeneration of the viscera). N Engl J Med. 1971;285:1339-1343.
267. Russell EJ, Zimmerman RD, Leeds NE, et al. Reye syndrome: computed tomographic documentation of disordered intracerebral structure. J Comput Assist Tomogr. 1979;3:217-220.
268. Giannotta SL, Hopkins J, Kindt GW. Computerized tomography in Reye's syndrome: evidence for pathological cerebral vasodilatation. Neurosurgery. 1978;2:201-204.
269. Aoki N. Acute toxic encephalopathy with symmetrical low density areas in the thalami and the cerebellum. Childs Nerv Syst. 1985;1:62-65.
270. Ozdoba C, Pfenninger J, Schroth G. Initial and follow-up MRI in a case of early diagnosed Reye's syndrome. Neuroradiology. 1997;39:495-498.
271. Kinoshita T, Takahashi S, Ishii K, et al. Reye's syndrome with cortical laminar necrosis: MRI. Neuroradiology. 1996;38:269-272.
272. Malzberg MS, Rogg JM, Tate CA, et al. Poliomyelitis: hyperintensity of the anterior horn cells on MR images of the spinal cord. AJR Am J Roentgenol. 1993;161:863-865.
273. Kornreich L, Dagan O, Grunebaum M. MRI in acute poliomyelitis. Neuroradiology. 1996;38:371-372.
274. Kibe T, Fujimoto S, Ishikawa T, et al. Serial MRI findings of benign poliomyelitis. Brain Dev. 1996;18:147-149.
275. Carod-Artal FJ, Vargas AP, del Negro MC, et al. [Magnetic resonance findings of the anterior horns of the spinal cord in a patient with post-polio syndrome.] Rev Neurol. 1999;29:789.
276. Rao DG, Bateman DE. Hyperintensities of the anterior horn cells on MRI due to poliomyelitis. J Neurol Neurosurg Psychiatry. 1997;63:720.
277. Hinson VK, Tyor WR. Update on viral encephalitis. Curr Opin Neurol. 2001;14:369-374.
278. Zak IT, Altinok D, Merline JR, et al. West Nile virus infection. AJR Am J Roentgenol. 2005;184:957-961.
279. Ali M, Safriel Y, Sohi J, et al. West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol. 2005;26:289-297.
280. Kalita J, Misra UK, Pandey S, et al. A comparison of clinical and radiological findings in adults and children with Japanese encephalitis. Arch Neurol. 2003;60:1760-1764.
281. Saha M, Kumar S, Das A, et al. Similarities and differences of MR findings between Japanese encephalitis and Wilson's disease. Eur Radiol. 2002;12:872-876.
282. Huang CC, Liu CC, Chang YC, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341:936-942.
283. Nolan MA, Craig ME, Lahra MM, et al. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology. 2003;60:1651-1656.
284. Chua KB, Goh KJ, Wong KT, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999;354:1257-1259.
285. Einsiedel L, Kat E, Ravindran J, et al. MR findings in Murray Valley encephalitis. AJNR Am J Neuroradiol. 2003;24:1379-1382.
286. Kienzle N, Boyes L. Murray Valley encephalitis: case report and review of neuroradiological features. Australas Radiol. 2003;47:61-63.
287. Laothamatas J, Hemachudha T, Mitrabhakdi E, et al. MR imaging in human rabies. AJNR Am J Neuroradiol. 2003;24:1102-1109.